These findings are in line with Geyer et al.,48 who propose that low-grade DCIS have 1q gains and 16q losses, whereas more aggressive high-grade lesions have additional aberrations in for example 8q (MYC), 17q (ERBB2) or 20q (PTK6). The gene discussed is MYC; the disease is ductal breast carcinoma in situ.